Study of Personalized Melphalan Dosing in the Setting of Autologous Transplant
Status:
Withdrawn
Trial end date:
2021-03-31
Target enrollment:
Participant gender:
Summary
This randomized phase II trial studies the side effects and how well melphalan hydrochloride
works in treating patients with multiple myeloma that has come back or does not respond to
treatment. Drugs used in chemotherapy, such as melphalan hydrochloride, work in different
ways to stop the growth of cancer cells, either by killing the cells, by stopping them from
dividing, or by stopping them from spreading.